Background: There are many limitations with the evidence base for the role of race and ethnicity in continuation of psychotherapy for depression.
INTRODUCTION
Multiple lines of evidence reveal inequities in our healthcare systems.
For example, in a study of over 1 million patients who received a psychiatric diagnosis in 2011 across 11 not-for-profit healthcare systems in the United States (US), racial and ethnic minorities on average were less likely to receive a diagnosis for depression and initiate pharmacotherapy, but were more likely to initiate psychotherapy . A subsequent study explored the relationship between race and ethnicity and antidepressant adherence and found that even after adjustment for patient factors, such as age, education, income, insurance type, disease burden, mental healthcare use, and type of prescribing provider, patients' race and ethnicity were the strongest predictors of adherence to medication treatment for depression .
Findings for racial and ethnic minority patients' adherence (commonly referred to as "retention") to psychotherapy treatment for depression are mixed. There have now been three meta-analyses of studies on factors associated with psychotherapy retention for a number of mental health conditions. (Cooper & Conklin, 2015 & Greenberg, 2012; Wierzbicki & Pekarik, 1993) The oldest metaanalysis (Wierzbicki & Pekarik, 1993) observed variation in effects for race and ethnicity depending upon how they analyzed the data. Simple paired comparisons showed that non-white race was associated with lower retention; however, after adjustment for other factors such as socioeconomic status, these differences were no longer significant. Swift and Greenberg (2012) used more sophisticated meta-analytic multilevel models and found no effect of race and ethnicity on psychotherapy retention after accounting for other patient demographics, as well as provider-, treatment-and system-level variables. Finally, Cooper and Conklin (2015) only included randomized controlled trials in their meta-analysis and found that after accounting for other patient demographics, as well as provider-, treatment-and system-level variables, those studies with higher proportions of non-white patients had lower psychotherapy retention rates.
There were many limitations with these meta-analyses. One was that even though they covered several hundred published studies, only about 40% included information for patient race and ethnicity (individual sample size for these studies was not reported). Another was that various definitions for retention were used across individual studies included in the reviews and this contributed significantly to findings for at least one of the meta-analyses (Swift & Greenberg, 2012) .
Finally, several mental health conditions were included in these metaanalyses, so the findings for depression treatment alone were not clear.
Our study is designed to address these limitations by 1) including a large, diverse ethnic sample, 2) focusing on depression treatment, and 3) having a uniform definition of psychotherapy retention to address the question of how much a patient's racial and ethnic background contributes to the likelihood that they will return for a second psychotherapy visit within 45 days after their initial visit.
METHODS

Data sources
Data were obtained from six healthcare systems in the Mental Health Research Network (MHRN), a consortium of public-domain research centers affiliated with 13 large not-for-profit healthcare systems that each provide comprehensive care (HCSRN, 2017) . All MHRN healthcare systems organize electronic medical record data, insurance claims, and other administrative data into a Virtual Data Warehouse (VDW) to facilitate population-based research (Ross et al., 2014) .
Access to the dataset used for this study and its documentation are available by request from the MHRN data website (MHRN, 2017) .
Group Health Cooperative, HealthPartners, Henry Ford Health System, Kaiser Permanente Colorado, Kaiser Permanente Hawaii, and Kaiser Permanente Southern California contributed data to this study.
Combined, these systems provide care to 6.8 million members and/or patients. Based on previous research , the rates of diagnosed depression in these systems overall were 9.6% (n = 652,800 patients affected by depression).
Patients are enrolled through employer-sponsored insurance plans, individual insurance plans, and capitated Medicaid and Medicare programs, and are generally representative of each system's regional population. Group Health, HealthPartners, and Henry Ford are mixed-model healthcare systems that provide care through both internal and external providers, so at these sites analytic samples were limited to patients who were also health plan members. Each healthcare system's Institutional Review Board approved all study procedures.
Study population
The study sample consisted of patients 18 and older who had a "new" episode of psychotherapy treatment between 1/1/2010 and 12/31/2013 and who were continuously enrolled in the healthcare systems for at least 270 days prior to the psychotherapy episode.
These enrollment criteria were chosen so that we could determine if patients were receiving ongoing pharmacotherapy for depression. A "new" episode had a washout period (i.e., no psychotherapy visits) for at least 270 days prior to the index psychotherapy visit and was not necessarily a patient's first time in psychotherapy.
We defined psychotherapy treatment using standardized procedural terminology codes for diagnostic interviews/assessments and individual psychotherapy (HMSA Provider Resource Center, 2017). We did not consider appointments that were less than 30 min because in the health systems included in this study these appointments were primarily associated with medication management and/or initial assessment for referral to treatment. The procedural codes had to be accompanied by a depression diagnosis (ICD9 diagnoses 296.2, 296.3, 300.4, or 311) in the period starting 90 days before the index psychotherapy visit that was the start of the new episode (designated by the procedural codes) and ending 15 days after. Patients were excluded if they had a diagnosis of schizophrenia or bipolar disorder in this same period (90 days before to 15 days after).
Measures
Patient demographics
Each healthcare system implemented meaningful use requirements (Blumenthal & Tavenner, 2010) to collect self-reported gender and race and ethnicity data, which were recorded in the health system's electronic medical record and incorporated into the VDW. We followed national guidelines to create mutually exclusive race and ethnicity categories (Institute of Medicine, 2009; Taylor, Martinez, & Velasco, 2012) . Patients' self-reporting Hispanic ethnicity were considered Hispanic regardless of the race category they endorsed, following recommendations from a US survey that found that Hispanics consider themselves a race of people and not an ethnicity (Taylor et al., 2012) . If a patient's records contained two or more race categories (rather than a single category of "mixed race"), they were assigned the least prevalent race category in the US population to maximize the ability to understand differences in diagnoses and treatment for the least represented racial groups. Patients for whom race and ethnicity data were missing were classified in the unknown group. Education and income are not commonly collected at the individual level in the healthcare systems included in this study and thus education and income were estimated for each patient based upon blocks in the 2010 U.S. census.
Comorbidity burden
Disease burden was assessed by calculating a modified Charlson Comorbidity Index for each patient. Diagnosis codes assessed in the year before the index psychotherapy visit were used to provide a summary score assessing a patient's risk for 10-year mortality based upon 22 different health conditions (Charlson, Pompei, Ales, & MacKenzie, 1987) .
Mental health treatment status
Data for up to five years prior to the date of the index psychotherapy visit for each patient in our sample were used to identify mental health visits (defined as visits to specialty mental health providers or visits to general medical providers with a recorded mental health diagno- Swift and Greenberg (2012) provided a summary of the various definitions in the literature used to define psychotherapy retention/discontinuation/drop out. These included 1) failure to complete a prescribed course of treatment, 2) not having a certain number of visits, 3) missing appointments and not rescheduling them, 4) therapist judgment that treatment was terminated after a patient discontinued, and 5) patient discontinuing treatment before a clinically significant change was seen. Because we were using existing electronic medical record billing codes to define a psychotherapy visit, we could only use the third definition. We used failure to attend a second psychotherapy visit within 45 days of the index psychotherapy visit as our outcome, which is a measure of psychotherapy return rather than drop out or discontinuation since patients had only attended an initial visit. We used probability of returning for a second visit rather than reaching some minimum number of visits because the greatest psychotherapy attrition occurs following the first visit (Simon, Ding, Hubbard et al., 2012 . 
Analysis
Outcome definition
Statistical models
We fit a multilevel logistic regression model with a random intercept for each provider to predict psychotherapy return while adjusting for provider characteristics (Raudenbush & Bryk, 2002 ). An intraclass correlation was used to describe how much return rates varied from provider to provider while at the same time controlling for differences in patient characteristics (Wu, Crespi, & Wong, 2010 
Sensitivity analyses
We conducted three main sensitivity analyses: 1) using a 90-day definition for psychotherapy return instead of 45 days, 2) removing providers who appeared to only perform assessments and/or diagnostic visits and thus their patients would not be expected to return, and 3) removing patients who lost their membership before they had a chance to return for another psychotherapy visit (i.e., before 45 days of time passed after the initial "new" psychotherapy episode). We defined providers who primarily conducted assessment interviews as those who had < 10% of their patients with return visits at the point of the 45 day psychotherapy visit. This cutoff was selected through a visual inspection of the distribution of raw return rates by providers.
RESULTS
Patient characteristics
Descriptive statistics are provided in 
Psychotherapy return rates
Overall, the return visit rate was 47.6%. Characteristics of patients who did and did not return are shown in Table 1 . Adjusted results from the logistic model are shown in Table 2 . Provider-level differences accounted for 21% of the overall variation in the odds of returning for a second psychotherapy visit. All racial and ethnic minority patients had significantly lower odds of returning compared to the reference group 
Sensitivity analyses
Sensitivity analyses results are shown in the supplementary materials.
None of the sensitivity analyses substantially changed the main results.
DISCUSSION
We found that racial and ethnic minority patients were less likely to return for a second psychotherapy visit in the 45 days after their initial visit while controlling for the impact of other patient factors, healthcare system, and provider-level variability. However, differences by race and ethnicity were relatively small (aORs ranged from 0.80 to 0.90) compared to the large contribution healthcare systems and providers made to the likelihood that a patient would have a second psychotherapy visit. This is in contrast to our previous findings on TA B L E 2 Adjusted odds and 95% confidence intervals for the odds of returning for a second psychotherapy visit within 45 days of the initial visit. Provider level variation was accounted for by fitting a multilevel logistic regression model with a random intercept for each provider. Providers accounted for 21.1% of the variance in their clients' return visit rates
aOR (95% CI)
Age ( *Simultaneous antidepressant treatment was defined as at least two fills within 270 days prior to and/or at least two fills within 180 days after the date of the "new" psychotherapy episode start or antidepressant treatment was defined as starting pharmacotherapy within 30 days of the date of the "new" psychotherapy episode start.
depression medication adherence in the same population of patients using the same methods for data abstraction and analysis, where there were large differences between racial and ethnic minorities and non-Hispanic white patients and the impact of healthcare system and provider were minimal (Rossom, Shortreed, Coleman et al., 2016) . Thus, while potential differences for racial and ethnic groups of patients in return rates for psychotherapy remain an issue to monitor in mental health treatment, they were not substantial determinants of return rates in our study.
Our findings are supported by the limited literature in this area that providers and organizational culture contribute to dropout in psychotherapy. Potential factors, although some are controversial, include lack of racial, ethnic, and language concordance between providers and patients (Collado, Lim, & MacPherson, 2016; Sripada et al., 2016) , poor therapeutic alliance (Cooper et al., 2016; Johansson & Eklund, 2006) , and lack of cultural competence (Imel et al., 2011) . Implicit racial bias of healthcare providers, although not studied specifically in psychotherapy dropout and effectiveness, has been implicated in a number of studies on treatment outcomes in racial and ethnic minority patients (Green et al., 2007; Spoont et al., 2015) . There has also been some discussion about the fact that dropout is not necessarily an indicator of poor treatment (Simon, Imel, Ludman et al., 2012) . Patients may improve with fewer psychotherapy visits than recommended and discontinue psychotherapy, which would be considered a "good" outcome (Baldwin, Berkelion, Atkins, & Nielson, 2009; Imel, Sheng, Baldwin, & Atkins, 2015) . We were not able to examine outcomes in these patients; however; this would be an important addition to any future studies. These issues might be mitigated through system and provider sensitivity to the fact that patients may perceive such dynamics as possible barriers to returning for follow-up visits.
Organizational culture and standardization of evidence-based psychotherapy treatments for depression are areas that have not been studied systematically. We saw large differences in psychotherapy return rates within 45 days of the initial visit across healthcare systems, ranging from 39.8% to 69.8%. Although these sites also varied in their distribution of racial and ethnic minorities, we controlled for this in our analyses, suggesting that other organizational factors might have contributed to these differences. Some work in this area suggests that organizational and/or staff instability was an important predictor of dropout from psychotherapy treatment (Brandt, Bielitz, & Georgi, 2016; Werbart, Andersson, & Sandell, 2014) ; however, there was no way for us to index the level of instability in the various healthcare systems studied. There is clearly a need for more research in this area.
Although the healthcare systems within the MHRN value patient engagement and outreach, both to understand what individuals seek and expect from their mental health treatment, and to focus attention on quality improvement , it is unclear to what degree the systems included in this study implemented these practices. Unfortunately, a recent survey found that less than 25% of therapists regularly practice such engagement and retention activities, suggesting that greater emphasis on such interventions might be warranted (Westmacott & Hunsley, 2016) . Practicing this patient-centered approach could be particularly difficult in very large institutions. In our study, the population receiving psychotherapy varied from over 200,000 to less than 3,000. Thus, it could be expected that implementing psychotherapy retention strategies such as regular appointment reminders and patient-centered case management plans would be very different for 200,000 versus 3,000 patients.
There are important limitations with our study. We were not able to determine why provider and healthcare system were strong predictors of return to psychotherapy within 45 days of the initial visit. This would necessitate collection of data that were not available in electronic medical records such as patient-reported outcomes, patientprovider therapeutic alliance, provider training, fidelity to treatment, type of treatment used, engagement and retention efforts, culturallinguistic competence, and organizational standards and guidelines regarding types of psychotherapeutic treatments used for depression.
In addition, information about provider demographics, amount of clinical training, and type of clinical license was not widely available.
Another potential limitation of our study was that the window for return to treatment may have been too narrow given the challenges that many healthcare systems have with psychotherapy access and thus not representative of the population who attempted to make a return visit. However, when we extended the period of return to 90 days after the initial visit, our findings did not change (see supplemental material). Finally, also related to generalizability, our study had very few low-income patients whose challenges with adherence to any form of treatment are well documented independent of physician and healthcare system determinants. Our findings might have been different with indigent patients or those primarily receiving subsidized insurance.
Our overall rates of return to psychotherapy (47.6%) were lower than retention rates reported in the literature, although we were within the range reported for individual studies (25.8%-100%). The two most recent meta-analyses found overall retention rates of 80.3% (Swift & Greenberg, 2012) and 82.5% (Cooper & Conklin, 2015) . The older meta-analysis in this area reported a similar overall retention rate (53.4%) to ours (Wierzbicki & Pekarik, 1993) . One possible explanation for the differences between our return rates and those reported in the literature could be that our healthcare systems were different than those included in these meta-analyses. Recent studies have
shown that the type of practice determines psychotherapy return rates independent of demographics and insurance coverage (Simon, Ding, Hubbard et al., 2012 . In addition, our sample had a higher proportion of racial and ethnic minority patients than that reported in the literature. Cooper and Conklin (2015) found that randomized trials of psychotherapy treatment with larger proportions of non-Hispanic white patients were likely to report higher rates of drop out.
Finally, we defined psychotherapy as those visits that used standardized procedural terminology codes for diagnostic interviews/assessments and individual psychotherapy (HMSA Provider
Resource Center, 2017) and were at least 30 min long. It is possible that we may have missed psychotherapy visits of shorter duration and thus underestimated the rates of psychotherapy return. However, in our healthcare systems these shorter visits are almost always used for medication management even if psychotherapy also occurs and we wanted to be as certain as possible that we were studying psychotherapy treatment alone.
Despite these limitations, our study is one of the largest in the literature (n = 242,765 patients) examining the impact of race and ethnicity on psychotherapy return rates specifically for patients starting a new episode of depression treatment in real world healthcare systems while controlling for patient demographics and variation due to providers and healthcare systems. Although we did find lower retention rates for racial and ethnic minority patients, provider-and system-level variation were stronger predictors. Much more research is needed to understand why these were strong predictors.
CONCLUSIONS
In our previous work, we found that racial and ethnic minority patients were more likely to receive psychotherapy for their depression than pharmacotherapy. Given that psychotherapy may be the main treatment provided for/chosen by racial and ethnic minority patients, the implications from the current study findings suggest that efforts should be made to understand the provider and healthcare system level barriers to psychotherapy return and thus effective treatment for these patients. Key factors for study and possible improvement include therapeutic alliance, tailoring of psychotherapy approaches to these patients, cultural competence, implicit racial bias among providers, organizational culture, and the implementation of retention strategies such as appointment reminders and case management strategies.
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